Title:
THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE
Document Type and Number:
WIPO Patent Application WO/2015/012332
Kind Code:
A1
Abstract:
The present invention provides a therapeutic agent or a preventive agent for ophthalmic diseases caused by ocular neovascularization, the agent comprising as an active ingredient a morpholine compound represented by general formula (1)
(1)
[In the formula, ring A is an aryl, etc. which may have a substituent, ring B is an arylene, etc. which may have a substituent, m=0-2, n=1-5, X is a bond, etc., Y is a bond, etc., and Z is a hydrogen atom, etc.] or a pharmaceutically acceptable salt thereof.
Inventors:
HIGASHI HIDEMITSU (JP)
Application Number:
PCT/JP2014/069507
Publication Date:
January 29, 2015
Filing Date:
July 24, 2014
Export Citation:
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
International Classes:
A61K31/5375; A61K31/5377; A61P27/02; A61P27/06; C07D265/30; C07D413/12; C07D417/12; C07D417/14; C07D513/04
Domestic Patent References:
| WO2006028284A1 | 2006-03-16 | |||
| WO2008007691A1 | 2008-01-17 | |||
| WO2013079696A1 | 2013-06-06 |
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Takashima 1 (JP)
Download PDF: